GlassScriptPhysician profile
Gordon M Ortiz
NPI 1023068640
$3,791.34
in general payments reported to CMS, 2019-2025
22 companies · $372 in 2025
The $372 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2020: $335 · 2021: $468 · 2022: $591 · 2023: $1,287 · 2024: $319 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,265 · Travel and Lodging: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,264.53 |
| Travel and Lodging | $713.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,539.73 | 2021-2023 | Urolift |
| Medtronic, INC. | $742.26 | 2021-2024 | Interstim |
| Neotract INC. | $288.41 | 2019-2020 | |
| Medtronic USA, INC. | $236.99 | 2019-2020 | |
| Boston Scientific Corporation | $169.51 | 2020-2021 | |
| Profound Medical Corp. | $167.57 | 2025 | Tulsa-Pro |
| Dendreon Pharmaceuticals LLC | $148.24 | 2025 | Provenge |
| Urogen Pharma, INC. | $64.83 | 2023-2024 | Jelmyto |
| W. L. Gore & Associates, INC. | $60.28 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Olympus America INC. | $49.60 | 2023 | Itind System, Uretero-Reno Fiberscope |
| Bayer Healthcare Pharmaceuticals INC. | $45.41 | 2019-2020 | |
| Abbvie INC. | $43.43 | 2019-2023 | |
| Janssen Biotech, INC. | $41.68 | 2022-2024 | Akeega, Balversa, Erleada |
| Pfizer INC. | $29.52 | 2024-2025 | |
| Astellas Pharma US INC | $28.26 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $23.67 | 2025 | Gemtesa |
| Blue Earth Diagnostics | $23.55 | 2019 | |
| Laborie Medical Technologies Corp. | $21.32 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Halozyme INC | $20.67 | 2023 | |
| Antares Pharma, INC. | $18.24 | 2023 | Tlando, Xyosted, Nocdurna |
| Calyxo, INC. | $16.83 | 2025 | Cvac Aspiration System |
| Endo Pharmaceuticals INC. | $11.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gordon Ortiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.